Extraovarian peritoneal serous papillary carcinoma: A phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - A Gynecologic Oncology Group Study

Gynecologic Oncology

Volumn 89, Issue 1, 2003, Pages 148-154

  Bloss, Jeffrey D ^a,g   Brady, Mark F ^b   Liao, Shu Yuan ^c   Rocereto, Thomas ^d   Partridge, Edward E ^e   Clarke Pearson, Daniel L ^f  

^a UNIVERSITY OF MISSOURI   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ELI LILLY AND COMPANY   (United States)

Author keywords

Extraovarian peritoneal serous papillary carcinoma; Ovarian cancer; Primary peritoneal carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EVALUATION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG TOXICITY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OVARY CARCINOMA; PAPILLARY CARCINOMA; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROBABILITY; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0037385177     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00068-4     Document Type: Article

References (41)

1. Swerdlow M. Mesothelioma of the pelvic peritoneum reassembly papillary cystadenocarcinoma of the ovary case report . Am J Obstet Gynecol. 77:1959;197-200.
2. Resta L., Maiorano E., Zito F.A., Faggiano F., Loizzi O., Ferreri R., et al. Multifocal extraovarian serous carcinoma a histochemical and immunohistochemical study . Eur J Gynaecol Oncol. 9:1988;474-478.
3. Mills S.E., Anderson W.A., Fechner R.E., Austin M.B. Serous surface papillary carcinoma a clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma . Am J Surg Pathol. 12:1988;827-834.
4. Raju U., Fine G., Greenawald K.A., Ohorodnik J.M. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol. 20:1989;426-436.
5. Strnad C.M., Grosh W.W., Baxter J., Burnett L.S., Jones H.W., Greco F.A., Hainsworth J.D. Peritoneal carcinomatosis of unknown primary site in women a distinctive subset of adenocarcinoma. Ann Intern Med. 111:1989;213-217.
6. Feuer G.A., Shevchuk M., Calanog A. Normal-sized ovary carcinoma syndrome. Obstet Gynecol. 73:1989;786-792.
7. Bollinger D.J., Wick M.R., Dehner L.P., Mills S.E., Swanson P.E., Clarke R.E. Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma a histochemical and immunohistochemical comparison . Am J Surg Pathol. 13:1989;659-670.
8. Wick M.R., Mills S.E., Dehner L.P., Bollinger D.J., Fechner R.E. Serous papillary carcinomas arising from the peritoneum and ovaries. Int J Gynecol Pathol. 8:1989;179-188.
9. Dalrymple J.C., Bannatyne P., Russell H.J., Solomon H.J., Tattersall M.H.N., Atkinson K., et al. Extraovarian peritoneal serous papillary carcinoma a clinicopathologic study of 31 cases . Cancer. 64:1989;110-115.
10. Ranson D.T., Shreyaskumar R.P., Keeney G.L., Malkasian G.D., Edmonson J.H. Papillary serous carcinoma of the peritoneum. Cancer. 66:1990;1091-1094.
11. Fromm G.L., Gershenson D.M., Silva E.G. Papillary serous carcinoma of the peritoneum. Obstet Gynecol. 75:1990;75-89.
12. Cooper K., McCallum S. Primary serous papillary carcinoma of the peritoneum. S Afr Med J. 74:1988;131-133.
13. Kannerstein M., Churg J., McCaughey W.T.E., Hill D.P. Papillary tumors of the peritoneum in woman mesothelioma of papillary carcinoma . Am J Obstet Gynecol. 127:1977;306-314.
14. Kannerstein M., Churg J. Peritoneal mesothelioma. Hum Pathol. 8:1977;83-94.
15. Tobacman J.K., Tucker M.A., Kase R., Greene M.H., Costa J., Fraumeni J.F. Jr. Intraabdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer prone families. Lancet. 2:1982;795-797.
16. Chen K.T., Schooley J.L., Flam M.S. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol. 66:(Suppl.):1985;93-94.
17. Rosenblum M.A., Foster R.B. Probable pelvic mesothelioma report of a case and review of the literature . Obstet Gynecol. 18:1961;213-222.
18. Foyler A., Al-Jabi M., McCaughey W.T.E. Papillary peritoneal tumors in women. Am J Surg Pathol. 5:1981;241-249.
19. Gooneratne S., Sassone M., Blaustein A., Talerman A. Serous surface papillary carinoma of the ovary a clinicopathologic study of 16 cases . Int J Gynecol Pathol. 1:1982;258-269.
20. August C.Z., Musad T.M., Newton M. Multiple focal extraovarian serous carcinoma. Int J Gynecol Pathol. 4:1985;11-23.
21. Cuen K.T.K., Flam M.S. Peritoneal papillary serous carcinoma with long-term survival. Cancer. 58:1986;1371-1373.
22. White P.F., Merino M.J., Barwick K.W. Serous surface papillary carcinoma of the ovary a clinical, pathologic, ultrastructural, and immunohistochemical study of 11 cases . Pathol Annu. 20:1985;403-418.
23. Warhol M.S., Hunter N.J., Corson J.M. An ultrastructural comparison of mesotheliomas and adenocarcinoma of the ovary and endometrium. Int J Gynecol Pathol. 1:1982;125-134.
24. Winslow D.J., Taylor H.B. Malignant peritoneal mesotheliomas a clinicopathological analysis of 12 fatal cases . Cancer. 13:1960;127-136.
25. Lele S.B., Piver M.J., Matharu J., Tsukadu Y. Peritoneal papillary carcinoma. Gynecol Oncol. 31:1988;315-320.
26. McCaughey W.T.E. Papillary peritoneal neoplasms in females. Pathol Annu. 20:1985;387-404.
27. Lauchlan S.C. The secondary mullerian system. Obstet Gynecol. 27:1972;133-145.
28. Russell P., Bannatyne P.M., Solomon H.J., Stoddard L.D., Tattersall H.N. Multifocal tumorigenesis in the upper female genital tract implications for staging and management . Int J Gynecol Pathol. 4:1985;192-210.
29. Parmley T.H., Woodruff J.D. The ovarian mesothelioma. Am J Obstet Gynecol. 120:1974;234-241.
30. Moertel G.C. Peritoneal mesothelioma. Gastroenterology. 63:1972;246-350.
31. Jones D.E.C., Silver D. Peritoneal mesotheliomas. Surgery. 86:1979;556-580.
32. Lynch H.T., Bewtra C., Lynch J.F. Familial peritoneal ovarian carcinomatosis a new clinical entity . Med Hypotheses. 21:1986;171-177.
33. Bloss J.D., Shu-Yuan L., Buller R.E., Manetta A., Berman M.L., McMeekin S., et al. Extraovarian peritoneal serous papillary carcinoma a case-control retrospective comparison to papillary adenocarcinoma of the ovary . Gynecol Oncol. 50:1993;347-351.
34. McGuire W.P., Hoskins W.J., Brady M.F., Kuoera P.R., Partridge E.E., Look K.Y., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 334:1996;1-6.
35. Eltabbakh G.H., Piver M.S., Nachimuthu N., Mettlin C.J. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol. 91:1998;254-259.
36. Piuva B., Meirovitz M., Bartfiled M., Yanai-Inbar I., Cohen Y. Peritoneal papillary serous carcinoma; study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma. J Surg Oncol. 68:1998;173-178.
37. Kowalski L.D., Kanbour A.I., Price F.V., Finkelstein S.D., Christopherson W.A., Seski J.C., et al. A case-matched molecular comparison of extra-ovarian vs primary ovarian adenocarcinoma. Cancer. 79:1997;1587-1594.
38. Eltabbakh G.H., Piver M.S. Extraovarian primary peritoneal carcinoma. Oncology. 12:1998;813-819.
39. Gillette N., Disaia P.J. The Eltabbakh/Piver article reviewed. Oncology. 12:1998;825-826.
40. National Commission for Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: DHEW; 1978, Publ. No. (OS) 78-0012. http://ohrp.osophs.dhhs.gov/humansubjects/guidance/belmont.html.
41. Scully R.E. The Eltabbakh/Piver article reviewed. Oncology. 12:1998;820-825.